CAI
CAI
Indices, commodities, movers, heatmap, and top stories. No login required.
CAI
CAI NASDAQ
Caris Life Sciences Launches New National Commercial Featuring Jordan Spieth Highlighting the Power of Artificial Intelligence in Early Stage Cancer Detection
Caris Life Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026
Caris Life Sciences to Present Eight Studies Highlighting the Power of AI, Multi-Omics and Precision Medicine at ESMO 2026
Caris Life Sciences, Inc. $CAI Shares Newly Bought by City Center Advisors LLC
IPO Stock Of The Week: Caris Pulls Back After More Than Doubling In Just Two Months
Caris Life Sciences: Diagnostics Growth With Room To Run
Revenue & Net Income (5Y)
EPS & Growth (5Y)
Free Cash Flow (5Y)
Capital Returns
Operating & Net Margin (5Y)
CapEx vs. Free Cash Flow (5Y)
Capital Allocation (5Y)
R&D and SG&A Intensity (5Y)
EBITDA (5Y)
Cost of Revenue (5Y)
Market Cap (5Y)
Ask Blinx with professional market data, charts beside chat, and your portfolio context.
Default quotes are Lang & Schwarz. NASDAQ is the delayed listing price. Charts stay daily. Not investment advice.